Piramal Pharma Ltd.

₹152.45

1 (0.7%)

PPLPHARMA Share Price

Pharmaceuticals & Biotechnology

As on January 27, 2026

SectorHealthcare

IndustryPharmaceuticals & Biotechnology

Basic IndustryPharmaceuticals

Market Cap₹ 20,167 Cr

P/E Ratio221.55

Dividend Yield0.01 %

Trendline Performance

Unlock Stock of the Month

T&C*

Technicals

Indicators	Value	Signal
5-DMA	154.66	Bearish
10-DMA	160.8	Bearish
20-DMA	167.68	Bearish
50-DMA	175.31	Bearish
100-DMA	186.71	Bearish
200-DMA	195.58	Bearish

Historical Performance

1 Year

-31.9%

3 Years

51.8%

5 Years

N/A

10 Years

N/A

Shareholding Pattern

Values Analysis

Loading chart...

Profit & Loss

Below figures are in Rs. Crores

Particulars	Mar-2025	Mar-2024	Mar-2023	Mar-2022	Mar-2021
Net Sales	91,512	81,712	70,815	65,591	63,149
Total Expenditure	77,333	70,006	64,533	56,094	48,869
Other Income	1,618	2,011	2,251	2,758	1,641
Operating Profit	15,796	13,717	8,533	12,255	15,921
Interest	4,216	4,485	3,442	1,982	1,634
Depreciation	8,163	7,406	6,767	5,862	5,450
Profit Before Tax	4,146	1,793	-1,202	4,850	9,490
Consolidated Net Profit	911	178	-1,865	3,760	8,350
Adjusted EPS	1	---	-2	3	8

Compounded Sales Growth

10 Years:7.7

5 Years:7.7

3 Years:6.9

TTM:2.3

Compounded Profit Growth

10 Years:-35.8

5 Years:-35.8

3 Years:-24.7

TTM:38.6

Stock Price CAGR

10 Years:N/A

5 Years:N/A

3 Years:14.9

TTM:-30.3

Return on Equity

10 Years:N/A

5 Years:8.2

3 Years:-1.5

last year:0.7

Quarterly Results

Below figures are in Rs. Crores

Particulars	Sep-2024	Dec-2024	Mar-2025	Jul-2025	Sep-2025
Sales	1,70,754	1,35,936	1,28,552	1,22,189	1,05,161
Expenses	63,042	56,557	52,457	45,459	34,856
Operating Profit	1,07,712	79,379	76,096	76,730	70,304
OPM %	63%	58%	59%	63%	67%
Other Income	33,912	31,759	27,333	24,879	18,947
Interest	77,780	58,584	59,248	62,137	53,713
Depreciation	2,345	1,681	1,385	1,277	1,221
Profit Before Tax	61,498	50,873	42,796	38,195	34,318
Tax %	25%	25%	26%	29%	35%
Net Profit	46,149	38,151	31,857	27,296	22,446
EPS in Rs	83	69	58	50	42

Balance Sheet

Below figures are in Rs. Crores

Particulars	Mar-2025	Mar-2024	Mar-2023	Mar-2022	Mar-2021
Share Capital	13,243	13,229	11,933	11,859	9,946
Total Reserves	67,390	65,610	55,802	55,107	46,103
Long-Term Borrowings	---	---	---	---	---
Total Non-Current Liabilities	33,927	26,446	38,120	29,026	25,604
Other Current Liabilities	11,847	15,757	13,053	12,428	11,406
Short Term Borrowings	9,953	11,714	13,023	6,588	3,605
Total Liabilities	1,52,845	1,49,253	1,44,365	1,27,172	1,07,561
Capital Work in Progress	4,891	5,657	8,529	6,732	3,995
Long Term Loans & Advances	911	1,148	4,940	2,970	1,521
Currents Investments	196	1,447	4,271	504	---
Short Term Loans and Advances	4,789	4,450	4,879	5,048	3,955
Total Current Assets	57,970	54,645	48,435	41,519	37,491
Total Assets	1,52,845	1,49,253	1,44,365	1,27,172	1,07,561
Adjusted Book Value	61	60	55	55	55

Positive

(80 to 100)

Neutral

(60 to 79)

Negative

(0 to 59)

The stock has a high PE of 221.55, indicating expensive valuation or elevated growth expectations.
Over the last three years, the stock delivered a strong 3-year price CAGR of 15.2%, indicating sustained price appreciation.
The stock carries a high beta of 1.3, implying higher volatility and elevated risk.
In the last financial year, the company reported an EBITDA of ₹15796 million, reflecting positive operating performance.
In the previous financial year, the company generated revenue of ₹91512 million, indicating a large and established business.

Investment Calculator

Investment Amount:

₹

Investment Amount: ₹ 1000000

Current Value: ₹ 697552

No. of Shares: 4576 (Approx)

Performance:-30.2%

P/L: ₹-302448

NIFTY Performance: 9.7%

1 day Top Gainers